Brief: Sprint Bioscience Q1 Operating Result Swings To Loss Of SEK 6.7 Mln
May 15 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q1 OPERATING LOSS SEK 6.7 MILLION VERSUS PROFIT SEK 7.3
MILLION
YEAR AGO
* Q1 NET SALES SEK 4.6 MILLION VERSUS SEK 17.6 MILLION YEAR
AGO
Source text for Eikon: ID:nWkrc6Kc80
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program